Median delay from eligibility to ART initiation according to HIV disease progression among eligible subjects.

Effect of earlier initiation of ART on new AIDS events using ANCOVA estimation.

Eric W. Djimeu (6288515)
Anna C. Heard (6288518)

February 2019

Effect of earlier initiation of ART on new AIDS events using ANCOVA estimation.</p

Time from eligibility for ART (as determined by Ugandan National ART Guidelines of a CD4 count less than or equal to 250 cells/mm3) to initiation of ART.

Elvin H. Geng (232775)
Mwebesa B. Bwana (359500)
Jerome Kabakyenga (191981)
Winnie Muyindike (347414)
Nneka I. Emenyonu (359501)
Nicholas Musinguzi (359502)
Peter Mugyenyi (168847)
Jeffrey N. Martin (131623)
David R. Bangsberg (90411)

February 2013

The denominator in this analysis is restricted to the subset of patients who became eligible for ...

ART uptake among known HIV-positive individuals who participated in Round 2, at the start and by the end of Round 2.

Sian Floyd (239400)
Helen Ayles (42807)
Albertus Schaap (372843)
Kwame Shanaube (353723)
David MacLeod (466263)
Mwelwa Phiri (5620625)
Sam Griffith (438433)
Peter Bock (361592)
Nulda Beyers (305944)
Sarah Fidler (76851)
Richard Hayes (32740)

August 2018

ART uptake among known HIV-positive individuals who participated in Round 2, at the start and by the...

Kaplan-Meier curves of time to initiation of ART in relation to WHO HIV stage.

Dimie Ogoina (733312)
Finomo Finomo (733313)
Tubonye Harry (733314)
Otonyo Inatimi (733315)
Ikenna Ebuenyi (733316)
Wolo-wolo Tariladei (733317)
Abimbola Anne Afolayan (733318)

May 2015

The median time to ART initiation was significantly shorter in participants with stage 2 disease ...

Delay and number of pre-ART visits from eligibility to ART initiation or to loss to follow-up among eligible subjects.

Ndeye Fatou Ngom (5770661)
Mame Awa Faye (5770664)
Kiné Ndiaye (5770667)
Aminata Thiam (5770670)
Cheikh Tidiane Ndour (5770673)
Jean-François Etard (123661)
Papa Salif Sow (135540)
Moussa Seydi (163879)
Eric Delaporte (284745)
Amandine Cournil (262971)

September 2018

Delay and number of pre-ART visits from eligibility to ART initiation or to loss to follow-up among ...

Temporal evolution of the median of the estimated delay between HIV seroconversion and diagnosis by country of origin.

Mathieu Nacher (340458)
Antoine Adenis (292334)
Florence Huber (347157)
Edouard Hallet (5439458)
Philippe Abboud (669399)
Emilie Mosnier (583471)
Bastien Bideau (5439446)
Christian Marty (35734)
Aude Lucarelli (5439455)
Vanessa Morel (5439452)
François Lacapère (5439449)
Loïc Epelboin (458049)
Pierre Couppié (342022)

June 2018

Temporal evolution of the median of the estimated delay between HIV seroconversion and diagnosis ...

Intention-to-treat effects of ART eligibility on ART initiation and retention in HIV care.

Jacob Bor (799247)
Matthew P. Fox (213205)
Sydney Rosen (213204)
Atheendar Venkataramani (4265317)
Frank Tanser (78333)
Deenan Pillay (7888)
Till Bärnighausen (36281)

November 2017

Intention-to-treat effects of ART eligibility on ART initiation and retention in HIV care.</p

Association between clinical characteristics and lack of ART initiation across two enrollment periods among HIV-seropositive patients enrolled in CNICS (including deaths) with inverse probability of censoring weighting, 2003–2012.

Terra V. Fatukasi (4237399)
Stephen R. Cole (211299)
Richard D. Moore (340677)
William C. Mathews (149421)
Jessie K. Edwards (595952)
Joseph J. Eron (203951)

July 2017

Association between clinical characteristics and lack of ART initiation across two enrollment per...

Time to start ART after CHiP referral to HIV care, estimates from “time-to-event” analysis.

Sian Floyd (239400)
Helen Ayles (42807)
Albertus Schaap (372843)
Kwame Shanaube (353723)
David MacLeod (466263)
Mwelwa Phiri (5620625)
Sam Griffith (438433)
Peter Bock (361592)
Nulda Beyers (305944)
Sarah Fidler (76851)
Richard Hayes (32740)

August 2018

Time to start ART after CHiP referral to HIV care, estimates from “time-to-event” analysis.</p

ART program outcomes by time in HIV care among HIV-infected persons who registered for pre-ART and ART care between April 2012 and March 2013 in Lilongwe, Malawi.

Hannock Tweya (76185)
Ikwo Kitefre Oboho (4801161)
Salem T. Gugsa (4801143)
Sam Phiri (283102)
Ethel Rambiki (4801155)
Rebecca Banda (4801146)
Johnbosco Mwafilaso (3541241)
Chimango Munthali (4801158)
Sundeep Gupta (727893)
Moses Bateganya (4801152)
Alice Maida (4801149)

January 2018

ART program outcomes by time in HIV care among HIV-infected persons who registered for pre-ART an...

Status of human immunodeficiency virus (HIV) diagnosis and antiretroviral therapy (ART) at the onset of AIDS-defining illnesses (ADIs).

Takeshi Tanaka (1531411)
Kazuhiro Oshima (8715612)
Kei Kawano (2207443)
Masato Tashiro (247574)
Akitaka Tanaka (11302035)
Ayumi Fujita (10954577)
Misuzu Tsukamoto (535646)
Akira Yasuoka (11302038)
Katsuji Teruya (212494)
Koichi Izumikawa (535642)

August 2021

(A) Time from HIV diagnosis to the onset of ADIs. The largest proportion of patients with ADIs were ...

Number of days from diagnosis to ART initiation by route of transmission and between cohorts.

Paul Kwok-ming Poon (13794169)
Ngai-sze Wong (13794172)
Wai-shing Leung (13794175)
Bonnie Chun-kwan Wong (13794178)
Tsz-shan Kwong (13794181)
Tsz-ho Kwan (13794184)
Grace Chung-yan Lui (13794187)
Owen Tak-yin Tsang (6175874)
Man-po Lee (13794190)
Ka-hing Wong (13794193)
Shui-shan Lee (13794196)

September 2022

(A) First cohort: HIV diagnosis 2007–2008; second cohort: HIV diagnosis 2016–2018. (B) ART-antiretro...

Time trends of antiretroviral therapy (ART) initiation.

Takeshi Tanaka (1531411)
Kazuhiro Oshima (8715612)
Kei Kawano (2207443)
Masato Tashiro (247574)
Akitaka Tanaka (11302035)
Ayumi Fujita (10954577)
Misuzu Tsukamoto (535646)
Akira Yasuoka (11302038)
Katsuji Teruya (212494)
Koichi Izumikawa (535642)

August 2021

(A) Time to ART initiation after diagnosis of acquired immunodeficiency syndrome-defining illnesses ...

Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients.

Fatukasi, Terra V
Cole, Stephen R
Moore, Richard D
Mathews, William C
Edwards, Jessie K
Eron, Joseph J
CNICS investigators

January 2017

Prompt initiation of combination antiretroviral therapy (ART) is important to reduce comorbidity and...

Figure 3

Felix R. Kayigamba (323333)
Mirjam I. Bakker (323334)
Hadassa Fikse (323335)
Veronicah Mugisha (289938)
Anita Asiimwe (289944)
Maarten F. Schim van der Loeff (102817)

February 2013

a. Time to enrolment among 482 HIV patients. b. Time to start of ART among 81 eligi...

Effect of earlier initiation of ART on new AIDS events using ANCOVA estimation.

Eric W. Djimeu (6288515)
Anna C. Heard (6288518)

February 2019

Effect of earlier initiation of ART on new AIDS events using ANCOVA estimation.</p

Time from eligibility for ART (as determined by Ugandan National ART Guidelines of a CD4 count less than or equal to 250 cells/mm3) to initiation of ART.

Elvin H. Geng (232775)
Mwebesa B. Bwana (359500)
Jerome Kabakyenga (191981)
Winnie Muyindike (347414)
Nneka I. Emenyonu (359501)
Nicholas Musinguzi (359502)
Peter Mugyenyi (168847)
Jeffrey N. Martin (131623)
David R. Bangsberg (90411)

February 2013

The denominator in this analysis is restricted to the subset of patients who became eligible for ...

ART uptake among known HIV-positive individuals who participated in Round 2, at the start and by the end of Round 2.

Sian Floyd (239400)
Helen Ayles (42807)
Albertus Schaap (372843)
Kwame Shanaube (353723)
David MacLeod (466263)
Mwelwa Phiri (5620625)
Sam Griffith (438433)
Peter Bock (361592)
Nulda Beyers (305944)
Sarah Fidler (76851)
Richard Hayes (32740)

August 2018

ART uptake among known HIV-positive individuals who participated in Round 2, at the start and by the...

Kaplan-Meier curves of time to initiation of ART in relation to WHO HIV stage.

Dimie Ogoina (733312)
Finomo Finomo (733313)
Tubonye Harry (733314)
Otonyo Inatimi (733315)
Ikenna Ebuenyi (733316)
Wolo-wolo Tariladei (733317)
Abimbola Anne Afolayan (733318)

May 2015

The median time to ART initiation was significantly shorter in participants with stage 2 disease ...

Delay and number of pre-ART visits from eligibility to ART initiation or to loss to follow-up among eligible subjects.

Ndeye Fatou Ngom (5770661)
Mame Awa Faye (5770664)
Kiné Ndiaye (5770667)
Aminata Thiam (5770670)
Cheikh Tidiane Ndour (5770673)
Jean-François Etard (123661)
Papa Salif Sow (135540)
Moussa Seydi (163879)
Eric Delaporte (284745)
Amandine Cournil (262971)

September 2018

Delay and number of pre-ART visits from eligibility to ART initiation or to loss to follow-up among ...

Temporal evolution of the median of the estimated delay between HIV seroconversion and diagnosis by country of origin.

Mathieu Nacher (340458)
Antoine Adenis (292334)
Florence Huber (347157)
Edouard Hallet (5439458)
Philippe Abboud (669399)
Emilie Mosnier (583471)
Bastien Bideau (5439446)
Christian Marty (35734)
Aude Lucarelli (5439455)
Vanessa Morel (5439452)
François Lacapère (5439449)
Loïc Epelboin (458049)
Pierre Couppié (342022)

June 2018

Temporal evolution of the median of the estimated delay between HIV seroconversion and diagnosis ...

Intention-to-treat effects of ART eligibility on ART initiation and retention in HIV care.

Jacob Bor (799247)
Matthew P. Fox (213205)
Sydney Rosen (213204)
Atheendar Venkataramani (4265317)
Frank Tanser (78333)
Deenan Pillay (7888)
Till Bärnighausen (36281)

November 2017

Intention-to-treat effects of ART eligibility on ART initiation and retention in HIV care.</p

Association between clinical characteristics and lack of ART initiation across two enrollment periods among HIV-seropositive patients enrolled in CNICS (including deaths) with inverse probability of censoring weighting, 2003–2012.

Terra V. Fatukasi (4237399)
Stephen R. Cole (211299)
Richard D. Moore (340677)
William C. Mathews (149421)
Jessie K. Edwards (595952)
Joseph J. Eron (203951)

July 2017

Association between clinical characteristics and lack of ART initiation across two enrollment per...

Time to start ART after CHiP referral to HIV care, estimates from “time-to-event” analysis.

Sian Floyd (239400)
Helen Ayles (42807)
Albertus Schaap (372843)
Kwame Shanaube (353723)
David MacLeod (466263)
Mwelwa Phiri (5620625)
Sam Griffith (438433)
Peter Bock (361592)
Nulda Beyers (305944)
Sarah Fidler (76851)
Richard Hayes (32740)

August 2018

Time to start ART after CHiP referral to HIV care, estimates from “time-to-event” analysis.</p

ART program outcomes by time in HIV care among HIV-infected persons who registered for pre-ART and ART care between April 2012 and March 2013 in Lilongwe, Malawi.

Hannock Tweya (76185)
Ikwo Kitefre Oboho (4801161)
Salem T. Gugsa (4801143)
Sam Phiri (283102)
Ethel Rambiki (4801155)
Rebecca Banda (4801146)
Johnbosco Mwafilaso (3541241)
Chimango Munthali (4801158)
Sundeep Gupta (727893)
Moses Bateganya (4801152)
Alice Maida (4801149)

January 2018

ART program outcomes by time in HIV care among HIV-infected persons who registered for pre-ART an...

Status of human immunodeficiency virus (HIV) diagnosis and antiretroviral therapy (ART) at the onset of AIDS-defining illnesses (ADIs).

Takeshi Tanaka (1531411)
Kazuhiro Oshima (8715612)
Kei Kawano (2207443)
Masato Tashiro (247574)
Akitaka Tanaka (11302035)
Ayumi Fujita (10954577)
Misuzu Tsukamoto (535646)
Akira Yasuoka (11302038)
Katsuji Teruya (212494)
Koichi Izumikawa (535642)

August 2021

(A) Time from HIV diagnosis to the onset of ADIs. The largest proportion of patients with ADIs were ...

Number of days from diagnosis to ART initiation by route of transmission and between cohorts.

Paul Kwok-ming Poon (13794169)
Ngai-sze Wong (13794172)
Wai-shing Leung (13794175)
Bonnie Chun-kwan Wong (13794178)
Tsz-shan Kwong (13794181)
Tsz-ho Kwan (13794184)
Grace Chung-yan Lui (13794187)
Owen Tak-yin Tsang (6175874)
Man-po Lee (13794190)
Ka-hing Wong (13794193)
Shui-shan Lee (13794196)

September 2022

(A) First cohort: HIV diagnosis 2007–2008; second cohort: HIV diagnosis 2016–2018. (B) ART-antiretro...

Time trends of antiretroviral therapy (ART) initiation.

Takeshi Tanaka (1531411)
Kazuhiro Oshima (8715612)
Kei Kawano (2207443)
Masato Tashiro (247574)
Akitaka Tanaka (11302035)
Ayumi Fujita (10954577)
Misuzu Tsukamoto (535646)
Akira Yasuoka (11302038)
Katsuji Teruya (212494)
Koichi Izumikawa (535642)

August 2021

(A) Time to ART initiation after diagnosis of acquired immunodeficiency syndrome-defining illnesses ...

Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients.

Fatukasi, Terra V
Cole, Stephen R
Moore, Richard D
Mathews, William C
Edwards, Jessie K
Eron, Joseph J
CNICS investigators

January 2017

Prompt initiation of combination antiretroviral therapy (ART) is important to reduce comorbidity and...

Figure 3

Felix R. Kayigamba (323333)
Mirjam I. Bakker (323334)
Hadassa Fikse (323335)
Veronicah Mugisha (289938)
Anita Asiimwe (289944)
Maarten F. Schim van der Loeff (102817)

February 2013

a. Time to enrolment among 482 HIV patients. b. Time to start of ART among 81 eligi...

Effect of earlier initiation of ART on new AIDS events using ANCOVA estimation.

Eric W. Djimeu (6288515)
Anna C. Heard (6288518)

February 2019

Effect of earlier initiation of ART on new AIDS events using ANCOVA estimation.</p

Time from eligibility for ART (as determined by Ugandan National ART Guidelines of a CD4 count less than or equal to 250 cells/mm3) to initiation of ART.

Elvin H. Geng (232775)
Mwebesa B. Bwana (359500)
Jerome Kabakyenga (191981)
Winnie Muyindike (347414)
Nneka I. Emenyonu (359501)
Nicholas Musinguzi (359502)
Peter Mugyenyi (168847)
Jeffrey N. Martin (131623)
David R. Bangsberg (90411)

February 2013

The denominator in this analysis is restricted to the subset of patients who became eligible for ...

ART uptake among known HIV-positive individuals who participated in Round 2, at the start and by the end of Round 2.

Sian Floyd (239400)
Helen Ayles (42807)
Albertus Schaap (372843)
Kwame Shanaube (353723)
David MacLeod (466263)
Mwelwa Phiri (5620625)
Sam Griffith (438433)
Peter Bock (361592)
Nulda Beyers (305944)
Sarah Fidler (76851)
Richard Hayes (32740)

August 2018

ART uptake among known HIV-positive individuals who participated in Round 2, at the start and by the...

Median delay from eligibility to ART initiation according to HIV disease progression among eligible subjects.

Abstract

Extracted data

Median delay from eligibility to ART initiation according to HIV disease progression among eligible subjects.

Abstract

Extracted data

Related items

Related items